Colchicine Tablet, Film Coated
Product Images NDC 60687-727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Colchicine (NDC 60687-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.6 mg Colchicine Tablet Blister (Blister)

0.6 mg Colchicine Tablet Blister (Blister)
Labels for Colchicine 0.6 mg film-coated tablets, USP, by American Health Packaging. Each label shows the product name, strength, dosage form, lot number placeholder, expiration date placeholder, and barcode. The labels are arranged in a sheet layout for printing.*
FDA Label Image

0.6 mg Colchicine Tablets Carton (Carton)

0.6 mg Colchicine Tablets Carton (Carton)
Drug facts panel for Colchicine tablets, USP, 0.6 mg strength, containing 30 film-coated tablets (3 x 10). The label includes dispensing instructions for the pharmacist, active ingredient content, storage conditions, safety warnings about child access, and distributor information for American Health Packaging in Columbus, Ohio.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of colchicine showing its molecular arrangement with various methoxy groups and a lactone ring characteristic of the compound.*
FDA Label Image

Figure 1 Pain Relief On Low And High Doses Of Colchicine And Placebo (cumulative) (Image 01)

Figure 1 Pain Relief On Low And High Doses Of Colchicine And Placebo (cumulative) (Image 01)
A line graph comparing the percentage of patients improved across different levels of percentage improvement for Colchicine low-dose (1.8 mg), Colchicine high-dose (4.8 mg), and placebo groups. The x-axis represents percentage improvement from greater than 0 to 100 or more, while the y-axis represents the percentage of patients improved from 0 to 100 percent. Three separate lines illustrate treatment response over the improvement range.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.